Document Type
Article
Publication Date
2016
Abstract
New gene-editing technologies, like CRISPR, promise revolutionary advances in biology and medicine. However, several patent disputes in the USA and UK may have complicated who can use CRISPR. What does this mean for the future of gene editing?
Recommended Citation
Biochemist, Vol. 38, p. 26 (2016)
COinS